ARTICLE | Clinical News
TAP reports Phase III Spectracef data
September 18, 2000 7:00 AM UTC
TAP Pharmaceuticals (Deerfield, Ill.) said that in a Phase III study of its Spectracef cefditoren pivoxil oral cephalosporin antibiotic to treat acute bacterial exacerbations of chronic bronchitis, th...